This project has received funding from the Innovative Medicines Initiative 2 Join Undertaking under grant agreement No 853966. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The total budget is 26M€ for a project duration of 42 months.

Find out more about

Our Groups, Centres and Units

Our Research Themes

Our Clinical Trials

Our Programme Grants

Search results

Showing results for

Nirmatrelvir-ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022-23: virological and immunological results of an open-label randomised trial (PANORAMIC).

Multi-objective optimisation of 3D-printed multilayer TPMS osteochondral scaffolds for enhanced mechanical and biological performance

Subharmonics are not an infallible safety metric for cavitation dynamics.

Association between SARS-CoV-2 and diabetes: A population-based cohort study using the UK CPRD GOLD database.

TTC7A deficiency: A retrospective international study on treatment and outcomes from the Inborn Errors Working Party of EBMT.

A concise guide to setting up a germ-free unit

Protocol for the co-design and development of PRIORITY-CONNECT SMS: An AI-driven, avatar-based multidisciplinary video intervention to enhance recovery after gastrointestinal cancer surgery

Mitigating health inequities with machine learning: a nationwide cohort study developing and evaluating ethnicity-specific cardiovascular risk prediction models across 19 ethnically diverse populations in 2.5 million individuals with COVID-19

Rapid Normal Fibroblast-Tumour Crosstalk Promotes CAF-like Activation and Attenuates Mitomycin C Cytotoxicity in Bladder Cancer

Challenges and barriers to musculoskeletal injury research in sub-Saharan Africa : a modified Delphi study.

Epigenetic modulation of stromal cell states underpins pathological tissue niches in Crohn's disease.

Adaptive deep brain stimulation for gait using a device embedded inertial sensor

Development and Validation of the Idiopathic Multicentric Castleman Disease Symptom Burden Scale (ISBUS): Protocol for an International Multistage Mixed Methods Study.

Reporting of external validation studies needs improvement: a systematic review of reporting in oncology prediction model studies.

Neutralising autoantibodies against IL-10 and HLA-DRB1*01:03 in paediatric patients with inflammatory bowel disease.

Correction: Academic impact and research data utilisation of the clinical practice research datalink: scientometric analyses.

Reliability of imaging assessment of fatty infiltration in rotator cuff disorders: protocol for a systematic review and meta-analysis.

GRIA3: proposal for a neuroimmune role linking infection, stress, chronic disorders and the activity of kynurenic acid

Antisense transcription reveals disease-associated adaptations in the human gut microbiome

Association of analgesics prescription with incident comorbidities in people with osteoarthritis—a UK Primary Care database cohort study

Meet the NDORMS team

Daniel Prieto-Alhambra

Read the press release

Supported by

Find out more about

Similar stories

NDORMS researchers win prestigious national leadership prizes

From Paraguay to Oxford: Mariela’s experience of the Trueta Bursary

Arthritis origins may begin before birth, study finds

NDORMS student wins national research prize

Trial exploring effects of drug on liver in psoriasis patients recruits first UK patient

NDORMS team wins Award for Excellence for transforming ulcerative colitis care

Cookies on this website

Search results

Showing results for

Meet the NDORMS team

Read the press release

Supported by

Find out more about

Similar stories